In Brief: Synthetic Design Lab Debuts With $20m To Advance Cutting-Edge ADCs

The company intends to move its first asset into clinical trials next year

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.